Shorla Oncology Inc.

Jylamvo

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Shorla Oncology Inc.

Jylamvo HCPCS:

J8611

HCPCS Code Descriptor:

Oral methotrexate (jylamvo)

Category:

J Code

Jylamvo NDCs:

81927-0204-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Glass bottle

Route of Administration:

Oral

Jylamvo CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Jylamvo:

Jylamvo is a medication manufactured by Shorla Oncology Inc. and aligned to the J Code: J8611. Jylamvo is administered via the Oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J8611 Added Date:

1-Jul-24

J8611 Effective Date:

1-Jul-24

J8611 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Jylamvo
Our team did not identify patient assistance information for Jylamvo
Jylamvo prescribing information can be found at the link below:
Our team did not identify a source of side effect information for Jylamvo.